Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France - Nantes Université
Article Dans Une Revue JAMA Network Open Année : 2022

Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France

Résumé

This cohort study assesses the incidence and severity of COVID-19 among vaccinated recipients of allogenic stem cell transplant in a single center after 1 or 2 messenger RNA booster doses during the Omicron wave in France.

Dates et versions

hal-04743269 , version 1 (18-10-2024)

Identifiants

Citer

Valentin Letailleur, Amandine Le Bourgeois, Thierry Guillaume, Maxime Jullien, Marianne Coste-Burel, et al.. Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France. JAMA Network Open, 2022, 5 (12), pp.e2247534. ⟨10.1001/jamanetworkopen.2022.47534⟩. ⟨hal-04743269⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More